Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting

被引:0
|
作者
Yang, Mo
MacEwan, Joanna P.
Boppudi, Sai Sriteja
McClain, Monica
O'Hara, Richard
Liu, Frank
Paik, Paul K.
机构
[1] EMD Serono, Rockland, MA USA
[2] Genesis Res, Hoboken, NJ USA
[3] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9051
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
    Gouran-Savadkoohi, Mohammad
    Mesci, Aruz
    Pond, Gregory R.
    Swaminath, Anand
    Quan, Kimmen
    Wright, Jim
    Tsakiridis, Theodoros
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 423 - +
  • [22] Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations
    Chen, Chi-Han
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Hsu, Ping-Chih
    Wu, Chiao-En
    ANTICANCER RESEARCH, 2022, 42 (04) : 2145 - 2157
  • [23] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    Medical Oncology, 2019, 36
  • [24] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [25] Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non-small cell lung cancer in real-world practice
    Huang, Xiaojie
    Pang, Guanchao
    Mao, Zhirong
    Li, Baizhou
    Teng, Zhihua
    Yang, Yan
    Qiu, Zijian
    Chen, Xiuxiu
    Wang, Pingli
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [26] Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell Lung Cancer
    Law, Jeanna Wallenta
    Bapat, Bela
    Sweetnam, Connor
    Mohammed, Hina
    Mcbratney, Ashleigh
    Izano, Monika A.
    Scannell Bryan, Molly
    Spencer, Scott
    Schroeder, Brock
    Hostin, Damon
    Berry, Anna B.
    Simon, George R.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [27] Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting
    Li, Jianjie
    Chi, Yujia
    Cao, Guang
    Zhao, Jun
    An, Tongtong
    Wu, Meina
    Wang, Yuyan
    Zhuo, Minglei
    Yang, Xue
    Jia, Bo
    Chen, Hanxiao
    Wang, Jingjing
    Zhai, Xiaoyu
    Wang, Ziping
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1813 - 1821
  • [28] REAL-WORLD BIOMARKER TESTING RATES AMONG PATIENTS WITH WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE UNITED STATES
    Vieira, M. C.
    Kelton, J. M.
    Lamarre, N.
    Abraham, A.
    Duncan, K.
    Krulewicz, S.
    VALUE IN HEALTH, 2022, 25 (07) : S437 - S437
  • [29] Real-world biomarker testing rates and trends among patients with advanced non-small cell lung cancer in the US
    Chen, Yiyu
    Carlson, Angeline
    CANCER RESEARCH, 2024, 84 (06)
  • [30] TOTAL COST OF CARE IN REAL-WORLD PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH ANTINEOPLASTIC THERAPY
    Radtchenko, J.
    Korytowsky, B.
    Bhor, M.
    Tuell, K.
    Feinberg, B.
    VALUE IN HEALTH, 2016, 19 (03) : A13 - A13